Open Access

Association between host TNF‑α, TGF‑β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV‑associated chronic liver disease in Indonesian patients

  • Authors:
    • Citrawati Dyah Kencono Wungu
    • Mochamad Amin
    • S. Eriaty N. Ruslan
    • Priyo Budi Purwono
    • Ulfa Kholili
    • Ummi Maimunah
    • Poernomo Boedi Setiawan
    • Maria Inge Lusida
    • Soetjipto Soetjipto
    • Retno Handajani
  • View Affiliations

  • Published online on: September 9, 2019     https://doi.org/10.3892/br.2019.1239
  • Pages: 145-153
  • Copyright: © Kencono Wungu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In developing countries, including Indonesia, there is a high mortality rate associated with the progression of hepatitis B virus (HBV)‑associated chronic liver disease (CLD). The pathogenesis of HBV infection is influenced by viral and host factors. To determine potential associations between these factors, host single nucleotide polymorphisms (SNPs) on TNF‑α, TGF‑β1 and p53, HBV X gene mutation and HBV viral load were investigated in patients with HBV‑associated CLD in Surabaya, Indonesia. Sera were collected from 87 CLD patients with HBV infection. TNF‑α, TGF‑β1 and p53 SNPs were genotyped by PCR restriction fragment length polymorphism. The HBV X gene was sequenced and compared with reference strains to determine mutations and the viral load was measured using reverse transcription‑quantitative PCR. In Indonesian patients, no association between TNF‑α, TGF‑β1 and p53 SNPs and CLD or X gene mutation were identified. A total of 23% (20/87) of samples had HBV X gene mutations, including ten substitution types, one deletion and one insertion. Multinomial regression analysis revealed that the K130M/V131I mutations were correlated with CLD progression (OR, 7.629; 95% CI, 1.578‑36.884). Significant differences in viral load were found in HBV‑infected patients who had X gene mutations, such as R87W/G, I127L/T/N/S and K130M/V131I mutations (P<0.05). The presence of K130M and V131I mutations may be predictive for the progression of HBV‑associated CLD in Indonesia.
View Figures
View References

Related Articles

Journal Cover

October-2019
Volume 11 Issue 4

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kencono Wungu C, Amin M, N. Ruslan S, Purwono PB, Kholili U, Maimunah U, Setiawan PB, Lusida MI, Soetjipto S, Handajani R, Handajani R, et al: Association between host TNF‑α, TGF‑β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV‑associated chronic liver disease in Indonesian patients. Biomed Rep 11: 145-153, 2019.
APA
Kencono Wungu, C., Amin, M., N. Ruslan, S., Purwono, P.B., Kholili, U., Maimunah, U. ... Handajani, R. (2019). Association between host TNF‑α, TGF‑β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV‑associated chronic liver disease in Indonesian patients. Biomedical Reports, 11, 145-153. https://doi.org/10.3892/br.2019.1239
MLA
Kencono Wungu, C., Amin, M., N. Ruslan, S., Purwono, P. B., Kholili, U., Maimunah, U., Setiawan, P. B., Lusida, M. I., Soetjipto, S., Handajani, R."Association between host TNF‑α, TGF‑β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV‑associated chronic liver disease in Indonesian patients". Biomedical Reports 11.4 (2019): 145-153.
Chicago
Kencono Wungu, C., Amin, M., N. Ruslan, S., Purwono, P. B., Kholili, U., Maimunah, U., Setiawan, P. B., Lusida, M. I., Soetjipto, S., Handajani, R."Association between host TNF‑α, TGF‑β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV‑associated chronic liver disease in Indonesian patients". Biomedical Reports 11, no. 4 (2019): 145-153. https://doi.org/10.3892/br.2019.1239